https://www.selleckchem.com/pr....oducts/cycloheximide
ΔSUV ≥ 66% was predictive of OS (HR=0.31, 95% CI 0.11-0.85, p=0.02) but not PFS (HR=0.47, 95% CI 0.19-1.13, p=0.09). Visual 5-PS on i-PET did not predict outcome. ΔSUV, but not visual analysis, on i-PET predicted OS in DLBCL although the low number of events limited the statistical analysis. These data may help guide future clinical trials using PET response-adapted therapy. This study was registered at clinicaltrials.gov as NCT00118209. Copyright © 2020 American Society of Hematology.SETTING Post-tonsillectomy pain in adults can
Like
Comment
Share
